Description

Residual symptoms of depression and antidepressant side effects (and resultant treatment non-adherence) are frequently encountered challenges in the long-term treatment of depression. The majority of patients who respond to antidepressant treatment continue to have residual, subsyndromal symptoms of depression, such as low mood, sleep or appetite disturbance, irritability and fatigue. In this talk, providers will learn to distinguish residual symptoms from side effects as well as strategies to combat them, such as dose adjustments, changes in dose timing, medication switches, and the use of complementary and alternative medicine.

Learning Objectives

At the end of this educational activity, participants should be able to:

  • Identify barriers to achievement and maintenance of recovery in depressed patients.

Faculty

  • Director of Research, Depression Clinical and Research Program, MGH
    Associate Professor of Psychiatry, Harvard Medical School

CME Information

Accreditation

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education. This activity has expired. CME/CE Released: June 15, 2011; Valid for credit through June 15, 2013.  

Credit Designation

Even though this event is no longer accredited, providing information regarding planning, disclosure, and conflict of interest is important to us. This activity was accredited by McLean Hospital. Please see the original CME information below:


Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of McLean Hospital and the Massachusetts General Hospital Academy. McLean Hospital is accredited by the ACCME to provide continuing medical education (CME) for physicians.

Credit Designation
McLean Hospital designates this continuing medical educational activity for a maximum of 1 AMA PRA Category 1 Credits(TM). Physicians should only claim credit commensurate with the extent of their participation in the activity.

Policy on Faculty and Provider Disclosure
It is the policy of McLean Hospital that faculty and providers disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). McLean Hospital has established policies in place that identify and resolve all conflicts of interest prior to this educational activity.

 

Faculty Disclosure Statements
In accord with the disclosure policy of McLean Hospital as well as guidelines set forth by the Accreditation Council on Continuing Medical Education, speakers have been asked to disclose any relationship they have to companies producing pharmaceuticals, medical equipment, devices, etc. that might be germane to the content of their lectures. Such disclosure is not intended to suggest or condone bias in any presentation, but is elicited to provide participants with information that might be of potential importance to their evaluation of a given talk. In addition, faculty have been asked to disclose any "off label" uses of pharmaceutical products and devices.  

 


 

 

Speakers:
The following speakers and/or planners have reported receiving something of value from a company whose product may be germane to the content of their presentations:
David Mischoulon, MD, PhD
Research Support:
Nordic Naturals, Ganeden, FisherWallace
Advisory/Consulting: Bristol-Meyers Squibb Company
Writing: Pamlab
Royalty: Royalties from Back Bay Scientific for PMS Escape (patent application pending); Royalties from Lippincott Williams & Wilkins, for textbook "Natural Medications for Psychiatric Disorders: Considering the Alternatives" (David Mischoulon and Jerrold F Rosenbaum, Eds.)
Speaking: Reed Medical Education (a company working as a logistics collaborator for the MGH Psychiatry Academy). The education programs conducted by the MGH Psychiatry Academy were supported through Independent Medical Education (IME) grants from pharmaceutical companies co-supporting programs along with participant tuition. Commercial entities currently supporting the MGH Psychiatry Academy are listed on the Academy's website www.mghcme.org.


 

Planners

The following planners of this activity have indicated that neither they nor their families have a significant financial interest or affiliation with the manufacturer of any commercial products or provider of commercial services:

Robert J. Birnbaum, MD, PhD: Planner

John A. Fromson, MD: Planner, reviewer

Anan Nathif, EdM: Planner

Tristan Gorrindo, MD: Planner


Hardware/Software Specifications: 

This internet-based CME activity is best experienced using Internet Explorer 8+, Mozilla Firefox 3+, Safari 4+. This Web site requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Adobe Acrobat, Microsoft PowerPoint, and Windows Media Player.

Optimal System Configuration:
Flash Player: Adobe Flash Player 10.1+
Browser: Firefox 3+, Internet Explorer 8.0+, Safari 4.0+, or Google Chrome 7.0+
Operating System: Windows XP+ or Mac OS X 10.4+
Internet Connection: 1 Mbps or higher

Minimum Requirements:
Windows PC:
500-MHz Pentium II; Windows XP or higher; 128 MB RAM; Video Card at least 64MB of video memory; Sound Card at least 16-bit; Macromedia Flash Player 10 or higher, audio playback with speakers for programs with video content; Firefox 1.1+, Internet Explorer 7.0+, Safari 1.0+, Google Chrome, or Opera
Macintosh:
Mac OS X 10.3 or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 64MB of video memory; Sound Card: at least 16-bit


Speakers

 

The following speakers and/or planners have reported receiving something of value from a company whose product may be germane to the content of their presentations:

David Mischoulon, MD, PhD

Research support from the Bowman Family Foundation, Bristol-Myers Squibb Co., Cederroth, FisherWallace, Ganeden, Lichtwer Pharma, Nordic Naturals, Laxdale (Amarin), Methylation Sciences, Inc. (MSI), and SwissMedica.

Honoraria for consulting, speaking, and writing from Pamlab, Bristol-Myers Squibb Co., Nordic Naturals, Virbac, Pfizer, Reed Medical Education, and the Massachusetts General Hospital Psychiatry Academy.

Royalties from Back Bay Scientific for PMS Escape, and from Lippincott Williams & Wilkins for published book “Natural Medications for Psychiatric Disorders: Considering the Alternatives.”